News . Data . Research
CATALYST PHARMACEUTICALS INC (NASDAQ: CPRX) Q2 2022 earnings call dated Aug. 10, 2022 Corporate Participants: Alicia Grande -- Chief Financial Officer Patrick J. McEnany -- Co-Founder, Chairman,
BioLife Solutions Inc. (NASDAQ: BLFS) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Troy Wichterman -- Chief Financial Officer Michael Rice -- Chairman &
Perrigo Co PLC (NYSE: PRGO) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Bradley Joseph -- Vice President, Global Investor Relations and
PetIQ, Inc. (NASDAQ: PETQ) Q2 2022 earnings call dated Aug. 09, 2022 Corporate Participants: Katie Turner -- Investor Relations McCord Christensen -- Chief Executive Officer and
Trxade Health Inc. (NASDAQ: MEDS) has been on a mission to digitalize the retail pharmacy experience by providing a platform for independent
10X Genomics Inc. (NASDAQ: TXG) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Cassie Corneau -- Investor Relations Serge Saxonov -- Chief Executive Officer,
Cara Therapeutics , Inc. (NASDAQ: CARA) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Iris Francesconi -- Chief Strategy Officer and Head
ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Lisa M. Wilson -- Investor Relations Nikhil Lalwani -- President and
FibroGen, Inc. (NASDAQ: FGEN) Q2 2022 earnings call dated Aug. 08, 2022 Corporate Participants: Michael Tung -- Vice President of Corporate Strategy and Investor
Canopy Growth Corporation (TSE : WEED) Q1 2023 earnings call dated Aug. 05, 2022 Corporate Participants: Tyler Burns -- Director of Investor Relations David
Amgen Inc. (NASDAQ: AMGN) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Arvind Sood -- Vice President, Investor Relations Robert A. Bradway -- Chairman
ABIOMED, Inc. (NASDAQ: ABMD) Q1 2023 earnings call dated Aug. 04, 2022 Corporate Participants: Nicole Nath -- Manager of Investor Relations Michael R. Minogue -- Chairman,
Cigna Corporation (NYSE: CI) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Ralph Giacobbe -- Senior Vice President and Head of Investor
Zoetis Inc. (NYSE: ZTS) Q2 2022 earnings call dated Aug. 04, 2022 Corporate Participants: Steven Frank -- Vice President of Investor Relation Kristin C.
Eli Lilly and Company (NYSE: LLY) reported second quarter 2022 earnings results today. Worldwide revenue decreased 4% to $6.49 billion compared to the
Moderna, Inc. (NASDAQ: MRNA) Q1 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Lavina Talukdar -- Senior Vice President and Head of Investor
Regeneron Pharmaceuticals Inc. (NASDAQ: REGN) Q2 2022 earnings call dated Aug. 03, 2022 Corporate Participants: Ryan Crowe -- Vice President of Investor Relations Leonard
CVS Health Corporation (NYSE: CVS) reported second quarter 2022 earnings results today. Total revenues increased 11% year-over-year to $80.6 billion. Net income
Sage Therapeutics, Inc. (NASDAQ: SAGE) Q2 2022 earnings call dated Aug. 02, 2022 Corporate Participants: Helen Rubinstein -- Director of Investor Relations Barry Greene -- Chief
AbbVie (NYSE: ABBV) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Elizabeth Shea -- Vice President, Head of Investor Relations Richard Gonzalez -- Chairman
ImmunoGen, Inc. (NASDAQ: IMGN) Q2 2022 earnings call dated Jul. 29, 2022 Corporate Participants: Anabel Chan -- Head of Investor Relations Mark Enyedy -- President &